The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Plasma-based Colorectal Cancer Screening Research & Development
Official Title: Clinical Sample Protocol for Plasma-based Colorectal Cancer Screening Research & Development
Study ID: NCT04027790
Brief Summary: The objective of this Clinical Sample Collection Study is to develop a biobank of appropriately collected plasma samples from colorectal cancer patients (i.e. AJCC/UICC stages 0, I, II, III) prior to therapeutic intervention, and from people reporting for colorectal cancer screening by colonoscopy, prior to bowel preparation.
Detailed Description: The objective of this Clinical Sample Collection Study is to develop a biobank of appropriately collected plasma samples from colorectal cancer patients (i.e. AJCC/UICC stages 0, I, II, III) prior to therapeutic intervention, and from people reporting for colorectal cancer screening by colonoscopy, prior to bowel preparation. Samples in the colorectal cancer biobank will be used to: 1) assess the clinical performance of novel biomarkers for colorectal cancer screening; 2) develop improved processing workflows for the Epi proColon® test; 3) develop an automated Epi BiSKit workflow.
Minimum Age: 45 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
University of South Florida, Tampa, Florida, United States
Springfield Clinic, Springfield, Illinois, United States
Ochsner Clinic Foundation, New Orleans, Louisiana, United States
Washington University, Saint Louis, Missouri, United States
University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States
Name: Theo deVos, PhD
Affiliation: Epigenomics, Inc
Role: STUDY_DIRECTOR